Managing Mass Antibiotic Dispensing Points of Dispensing (PODs)

Slide Note
Embed
Share

Understanding the management of Mass Antibiotic Dispensing PODs is crucial in emergency response situations. This overview covers topics such as the Strategic National Stockpile (SNS), Category A threat agents, pharmaceuticals, and how DSNS responds to various scenarios. Key objectives include defining SNS mission, identifying POD basics, policies, laws, and optimizing flow within POD management.


Uploaded on Jul 29, 2024 | 4 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. An Overview of Mass Antibiotic Dispensing POD Management

  2. PRESENTERS Glennis P. Gray, RN-BC, BSN, MSN Ann Savwoir, RPh Rhonda LeMora, MPA Wanda P. Rose, JD, MPH

  3. DISCLOSURE I have no financial interests or other relationship with manufacturers of commercial products, suppliers of commercial services, or commercial supporters. My presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

  4. Course Objectives Define SNS Mission, Assets, and Response Identify what a POD is and Define Mass Antibiotic Dispensing POD Basics Identify Policies, Laws, Resources and Supplies to Support Dispensing Define POD Management and Ways to Optimize Flow

  5. SNS Mission, Assets and Response

  6. The Strategic National Stockpile The Strategic National Stockpile (SNS) is a national repository of antibiotics, chemical antidotes, vaccines, antidotes, vaccines, antitoxins, life-support- mechanisms, intravenous administration and airway maintenance supplies, and medical/ surgical items.

  7. Category A Threat Agents SNS supplies countermeasures based on the following Category A threat agents: Smallpox Anthrax Botulism Plague Tularemia Viral Hemorrhagic Fevers Nerve agent Pandemic Influenza Radiological

  8. Pharmaceuticals and Medical Supplies Pharmaceuticals include: Radiation Countermeasures Oral and IV Antibiotics Nerve Agent Anti-dotes Vaccines Antitoxins and Anti-Virals Medical Supplies IV Administration Airway Management Supplies (pediatric and adult)

  9. DSNS Responds in Three Ways Rapid delivery of a broad spectrum for an ill defined threat Large shipments of specific items when a threat is known Technical assistance and advice

  10. Broad Spectrum Support 12 Hour Push Packages can deliver Pre-configured SNS material anywhere in the country within 12 hours or less. The state is responsible for subsequent transportation to treatment centers, dispensing sites, or other distribution nodes. Each 12 hour push package contains large amounts of pre packaged, individual regimens of oral antibiotics that come in multi-day, unit of use, labeled , child proof bottles.

  11. Strategic National Stockpile Components Push Pack/12 Hours Vendor Managed Inventory/ 24-36 hours

  12. 12 Hour Push Package Weights over 50 tons 130 Containers maximum Fits into a wide-body cargo aircraft Consumes 15,000 sq. ft. of floor space 524,000 10-day regimes Numbered and colored coded for easy identification

  13. States may also be assisted with the following: Specific Item Support Managed Inventory Vaccines Buy Power/ Surge Capacity Federal Medical Stations Technical Assistance and Advise Emergency Response Concept

  14. Point of Dispening and Mass Antibiotic Dispensing

  15. What is a POD? Point of dispensing (POD) - a place where a vaccine, antibiotic or other medication is dispensed quickly to a large group of people.

  16. Types of PODS Open POD- A public location like a University, school, or other large site where medications are dispensed to a large group of people. Closed PODs A private location where medications are dispensed to a specific group of people. Hospitals Assisted Living Centers/Nursing Homes Business/Industry (Occupational PODs)

  17. Four Phases of a Dispensing Campaign Phase 1 Notification Phase 2 Prophylaxis Phase 3 Set- Up Phase 4 Public Notification

  18. Things to Consider Prior to Opening a POD Pre-Event Policy Issues Special Needs/At Risk Populations The Dispensing Process Data Collection POD Forms Design POD Site Selection

  19. Main Goals of Dispensing Setting up POD s quickly Putting pills in people Providing Health Information

  20. Legal Issues

  21. Emergency Determinations and Declarations Public Health Emergency Emergency Use Authorization (EUA) Public Readiness and Emergency Preparedness Act

  22. Purblic Health Emergency Determination The Secretary may determine, after consultation with such public health officials that: A disease or disorder presents a public health emergency exists. Notice to Congress within 48 hours Terminates when the Secretary determines that the emergency no longer exists or after 90 days, whichever occurs first May be renewed by the Secretary for additional 90 day periods

  23. Why Determine a Public Health Emergency Access Public Health Emergency Funds ( when funds are available) Waive certain restrictions on requirements or medical countermeasure distribution Declare an emergency justifying emergency use of an investigational product

  24. What Doesn't need a Public Health Emergency Determination Deploy approved, licensed, or cleared countermeasures from the Strategic National Stockpile Provide temporary assistance to States and localities to meet health emergencies

  25. Emergency Use Authorization (EUA) Provides for the emergency use of investigational medical products not yet approved, licensed or cleared by the FDA.

  26. Why Issue An EUA? An investigational product may be the best available to meet an emergency involving a Chemical , Biological, Radiological, Nuclear (CBRN) agent The requirements for clinical investigations are difficult to meet in mass dispensing Informed Consent process may limit public health s ability to respond and contain the disease/outbreak Institutional Review Boards are not practical during a rapidly progressive public health emergency

  27. The Three Steps Necessary for an EUA Determination of an Emergency by Secretary of Homeland Security (DHS), or Department of Defense (DOD), or Health and Human Service Secretary (HHS), and Declaration of an Emergency by the US Secretary of Health and Human Services Issuance of EUA by FDA Commissioner

  28. Emergency Use Authorizations (EUAs) If FDA grants a request for an EUA, it is found that: An approved product may be used in a way inconsistent with the limitations of the approval; or A product that has not yet been approved may be permitted to be used despite lacking the quantum of data that would be necessary for full approval.

  29. EUA Termination Maximum of One Year Length of the Declared Emergency

  30. EUA Revocation Criteria of issuance of the EUA is no longer met The EUA is no longer necessary to protect the public health or safety

  31. Public Readiness and Emergency Preparedness Act Declaration Authorizes the Secretary to issue a declaration to provide immunity from liability protection (except for willful misconduct) for medical countermeasure development, distribution and administration protection, and provides national guidance. Authorizes an emergency fund in the U.S. Treasury for compensation for injuries from covered countermeasures

  32. Louisuana Emergency Powers Act 2003 The Louisiana Emergency Powers Act 2003 grants the State Health Officer, the Department of Health and Hospitals (DHH), and DHH OPH exclusive jurisdiction, control and authority to isolate or quarantine and to take such action as is necessary to accomplish the subsidence and suppression of diseases of all kinds in order to prevent their spread.

  33. POD Management

  34. POD Management Storage Clinical Aspects Traffic Management Parking Staff Mental Health

  35. Goals of a POD Team Provide prophylaxis to all people in an area who have been exposed to an agent in order to save lives and prevent illness Set up and operate a site that runs at maximum efficiency and effectiveness

  36. Requirements in POD Operations Weights of Dispensing Labeling Clinical accuracy Hours of operation Screening/triage Patient/ Education Medical Records Transportation

  37. POD Manager Responsibilities Setup and Operation of the POD according to the state/regional or local plan Coordinates the activities of the management staff Information flow and reporting requirements Appoints or acts as POD spokesperson

  38. Conclusion/Questions Mail Sign in Sheets to Continuing Education Program, DHH/OPH, Nursing Services, Bienville Building, 628 North 4th St., 3rd Floor, Baton Rouge, LA 70802, C/O Regina Williams, Regina.Williams@la.gov Sign in sheets can also be faxed to 225-342-0886 Attention: Regina Williams Please complete online evaluations at http://www. Surveymonkey.com/s/PodManagement Password: FLOW

  39. Contact Information Glennis Gray, RN-BC, BSN, MSN 8919 World Ministry Ave., Suite B, Baton Rouge, LA 70810 Glennis. Gray@la.gov You can learn more about the Strategic National Stockpile at http://www.bt.cdc.gov/stockpile

Related


More Related Content